Cubist Systematic Strategies’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.34M Buy
14,900
+10,300
+224% +$1.59M 0.01% 1469
2025
Q2
$773K Buy
4,600
+600
+15% +$89K ﹤0.01% 2070
2025
Q1
$551K Sell
4,000
-100
-2% -$12.7K ﹤0.01% 2120
2024
Q4
$485K Sell
4,100
-8,700
-68% -$1.02M ﹤0.01% 2192
2024
Q3
$1.41M Buy
12,800
+6,900
+117% +$721K 0.01% 1608
2024
Q2
$580K Buy
5,900
+1,600
+37% +$163K ﹤0.01% 2049
2024
Q1
$481K Sell
4,300
-1,100
-20% -$119K ﹤0.01% 2629
2023
Q4
$544K Sell
5,400
-23,200
-81% -$2.3M ﹤0.01% 2478
2023
Q3
$2.48M Sell
28,600
-20,000
-41% -$1.81M 0.02% 1220
2023
Q2
$4.6M Buy
48,600
+26,300
+118% +$2.22M 0.03% 900
2023
Q1
$1.68M Sell
22,300
-187,700
-89% -$14.2M 0.01% 1795
2022
Q4
$16.1M Buy
210,000
+56,500
+37% +$4.29M 0.09% 245
2022
Q3
$10.2M Buy
+153,500
New +$9.73M 0.06% 461

Other funds holding CAH

Cubist Systematic Strategies's CAH Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Cardinal Health (CAH) in Q3 2025, closing a stake of 214 shares — an estimated $33.1K sold.

Cubist Systematic Strategies first reported a position in CAH in Q2 2014 and held it in 42 quarters. The position peaked at $36.2M in Q4 2022. 1,226 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Cardinal Health position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 214 Cardinal Health shares in Q3 2025, an estimated $33.1K.
  • Cubist Systematic Strategies first reported a position in Cardinal Health in Q2 2014 and held it in 42 quarters.
  • Cubist Systematic Strategies's Cardinal Health position peaked at $36.2M in Q4 2022.
  • 1,226 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.